TANYA ROWELL: Open Payments
NPI 1841661329 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 16 payments from 7 companies in 2025. Trend: 2023 $222 · 2024 $528 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $246 |
| Novo Nordisk Inc | 4 | $134 |
| Lilly USA, LLC | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 3 | $122 |
| Corium, LLC | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| PFIZER INC. | 1 | $14 |
Products named: CAPLYTA, Wegovy, ZEPBOUND, AIRSUPRA, Azstarys, FARXIGA, BEXSERO, TRUMENBA.
Industry payments across AL — which companies pay providers there.
